Otis Brawley

Otis Brawley

Director/Board Member en PDS BIOTECHNOLOGY CORPORATION .

Fortuna: 2 M $ al 31/03/2024

64 años
Health Technology
Consumer Services
Commercial Services

Cargos activos de Otis Brawley

EmpresasCargoInicioFin
PDS BIOTECHNOLOGY CORPORATION Director/Board Member 03/11/2020 -
Independent Dir/Board Member 03/11/2020 -
LYELL IMMUNOPHARMA, INC. Director/Board Member 01/04/2021 -
Independent Dir/Board Member 01/04/2021 -
INCYTE CORPORATION Director/Board Member 27/09/2021 -
Independent Dir/Board Member 27/09/2021 -
AGILENT TECHNOLOGIES, INC. Director/Board Member 17/11/2021 -
Independent Dir/Board Member 17/11/2021 -
The Johns Hopkins University Corporate Officer/Principal 01/01/2019 -
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Director/Board Member - -

Historial de carrera de Otis Brawley

Antiguos cargos conocidos de Otis Brawley.

EmpresasCargoInicioFin
Chief Tech/Sci/R&D Officer 01/04/2007 01/12/2018
░░░░░ ░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ - -

Formación de Otis Brawley.

The University of Chicago Undergraduate Degree
Pritzker School of Medicine Doctorate Degree

Estadísticas

Internacional

Estados Unidos 16

Operativa

Director/Board Member 8
Independent Dir/Board Member 4
Corporate Officer/Principal 4

Sectorial

Health Technology 7
Consumer Services 5
Commercial Services 3

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas relacionadas

Empresas cotizadas4
INCYTE CORPORATION

Health Technology

AGILENT TECHNOLOGIES, INC.

Health Technology

PDS BIOTECHNOLOGY CORPORATION

Health Technology

LYELL IMMUNOPHARMA, INC.

Health Technology

Empresas privadas7

Health Technology

Miscellaneous

Commercial Services

Health Technology

Commercial Services

Georgia Cancer Center

The National Coalition For Cancer Research

Ver las conexiones de la empresa